Pål Stenmark receives funding for developing new treatments
Pål Stenmark, professor of biochemistry at Stockholm University, has been awarded 2.5 million SEK in funding from the Knut and Alice Wallenberg Foundation and SciLifeLab's Proof of Concept program for life sciences.
Apply for a Research Council Starting Grant with DBB?
We welcome expressions of interest from junior researchers who would like to apply for a Starting Grant (Etableringsbidrag) from the Swedish Research Council (Vetenskapsrådet; VR), with DBB as host department.
Revealing mechanism of potential anti-TB drug opens possibilities for further cure development
In a study published in PNAS (Proceedings of the National Academy of Sciences), researchers at Stockholm University describe the mode of action of a potential anti-tuberculosis (anti-TB) compound, lansoprazole sulphide.
We offer a broad selection of specialized courses held in English that can be taken both as freestanding courses or as part of one of our Master's programmes.
Membrane proteins are the primary target of many drugs. These proteins play a key role in regulating the body’s functions and communication between cells. Professor Erik Lindahl is developing new methods to study these proteins in situ in tissue.
We welcome expressions of interest from junior researchers who would like to apply for a Starting Grant (Etableringsbidrag) from the Swedish Research Council (Vetenskapsrådet; VR), with DBB as host department.